Browse Acute myelocytic leukemia topic

Subtopics (18)

Articles

1-88 out of 88 article(s)

Title	Author	Type	Date	Words
Eisai Inc. Receives Complete Response Letter from the U.S. Food and Drug Administration for Dacogen[R] (decitabine) for Injection sNDA in Acute Myeloid Leukemia.			Mar 7, 2012	1164
Eisai Inc. Receives Complete Response Letter from U.S. Food and Drug Administration for DACOGEN[R] (decitabine) for injection sNDA in Acute Myeloid Leukemia.			Mar 7, 2012	932
Leukemia cutis.	Babina, Tatyana; Miller, Luke; Thomas, Brian	Report	Mar 1, 2012	888
European Medicines Agency Approves Orphan Medicinal Product Application of DCPrime's Acute Myeloid Leukemia Vaccine.			Feb 1, 2012	443
Research and Markets: Acute Myeloid Leukemia Therapeutics Market (2010 - 2020) (Pipeline Assessment & Market Forecast In G8 Countries).		Industry overview	Dec 22, 2011	587
MarketsandMarkets: Acute Myeloid Leukemia Therapeutics Market in G8 Countries Worth $1.67 Billion by 2020.			Dec 19, 2011	783
Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML).			Dec 13, 2011	1197
Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA.			Oct 24, 2011	744
FDA Accepts DACOGEN[R] (Decitabine) sNDA Submission in Acute Myeloid Leukemia.			Jul 13, 2011	928
Eisai Announces FDA Acceptance of sNDA Submission for DACOGEN[R] (decitabine) in Acute Myeloid Leukemia.			Jul 13, 2011	1105
Interim Data From Phase 2 Trial of AC220 Monotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia With FLT3-ITD Activating Mutations.			Jun 13, 2011	1358
Interim Data from Phase 2 Trial of AC220 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia with FLT3-ITD Activating Mutations.			Jun 13, 2011	1344
Phase III Study of Dacogen[R] (decitabine) for Injection in Acute Myeloid Leukemia (AML) Presented at ASCO.		Clinical report	Jun 6, 2011	1457
Eisai and Janssen Announce the Presentation of DACOGEN[R] (decitabine) Data at ASCO from a Phase III Study in Patients with Acute Myeloid Leukemia.			Jun 6, 2011	1445
DACOGEN(R) (decitabine) Showed an Overall Survival Advantage Compared With the Accepted Standard Therapies in Older Patients With Newly Diagnosed De Novo or Secondary Acute Myeloid Leukemia.			Jun 6, 2011	890
ARIAD Announces Initial Clinical Data on Ponatinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia.			Jun 3, 2011	1205
New mutations evolve in cancer: acute myeloid leukemia data may aid choice of treatment.	Sanders, Laura		Apr 23, 2011	363
American Society of Hematology Partners with Agrupacion Mexicana para el Estudio de la Hematologia and National Cancer Institute to Improve Diagnosis of Acute Myeloid Leukemia in Mexico.			Apr 8, 2011	806
Research and Markets: Acute Myelogenous Leukemia Global Clinical Trials Review, Q4, 2010.			Mar 29, 2011	429
Synta Announces First Patient Treated in Phase 1 Trial of Elesclomol in Acute Myeloid Leukemia.			Feb 8, 2011	1199
Mutated gene predicts poor survival in AML.	McBride, Deborah	Brief article	Feb 1, 2011	255
Oral Presentation Showcases Results of MLN4924 in Patients with Acute Myeloid Leukemia or High-Grade Myelodysplastic Syndromes.		Clinical report	Dec 6, 2010	621
Nursing considerations for managing acute promyelocytic leukemia and its side effects: as seen in the Clinical Journal of Oncology Nursing.	Becze, Elisa	Disease/Disorder overview	Dec 1, 2010	1080
Researchers discover key mutation in acute myeloid leukemia.			Nov 10, 2010	115
Celator Pharmaceuticals Completes Enrollment in a Second Phase 2 Trial of CPX-351 in Acute Myeloid Leukemia.			Oct 26, 2010	907
Research and Markets: Acute Myeloid Leukemia (AML) - Pipeline Assessment and Market Forecasts to 2017.			Oct 4, 2010	647
Seattle Genetics Announces Phase IIb Trial of Lintuzumab (SGN-33) in Patients with Acute Myeloid Leukemia (AML) Did Not Meet Primary Endpoint.			Sep 13, 2010	998
Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma Now Available at ReportsandReports.			Sep 2, 2010	999
CytRx's Tamibarotene Eradicates Cancer in Advanced Acute Promyelocytic Leukemia After Failure of Other Therapies.			Jul 22, 2010	1616
Eisai Announces Results of Phase III Study of Dacogen[R] (Decitabine) for Injection in Acute Myeloid Leukemia (AML).		Report	Jun 30, 2010	1074
In utero alcohol exposure linked with childhood AML.	Mechcatie, Elizabeth		Jun 1, 2010	759
Celator(R) Pharmaceuticals Announces Positive Data From Phase 2 Study of CPX-351 in Acute Myeloid Leukemia.			May 3, 2010	746
A novel approach to treatment in childhood acute myeloblastic leukemia and myelodysplastic syndrome with high-dose methylprednisolone as a differentiation- and apoptosis-inducing agent of myeloid leukemic cells.	Hicsonmez, Gonul	Report	Mar 1, 2010	6395
The MDS Foundation Says Newly Published Study Finds VIDAZA[R] Prolongs Survival in Acute Myeloid Leukemia.		Clinical report	Feb 2, 2010	362
Research and Markets: Acute Myeloid Leukemia (AML) - Drug Pipeline Analysis and Market Forecasts to 2016.			Jan 26, 2010	934
Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells.	Huang, Sheng-Teng; Wang, Chen-Yu; Yang, Rong-Chi; Chu, Chih-Ju; Wu, Hsiao-Ting; Pang, Jong-Hwei S.	Report	Jan 1, 2010	5507
CytRx Announces Positive Phase 2 Results For Tamibarotene in the Treatment of Relapsed Acute Promyelocytic Leukemia.		Financial report	Dec 7, 2009	1396
Chakalaka-induced vasodilatation in patients with chronic myeloid leukaemia on tyrosine kinase inhibitors.	Coetzee, Marius J.; Louw, Vernon J.; Gartrell, Kevin; Viljoen, Chris D.	Report	Dec 1, 2009	1441
Intestinal mucus accumulation in a child with acute myeloblastic leukemia/Akut myeloblastik losemili bir cocukta intestinal mukus birikimi.	Malbora, Baris; Avci, Zekai; Ince, Deniz Anuk; Arikan, Unser; Ozbek, Namik	Case study	Dec 1, 2009	1116
CytRx and Cephalon Oncology Therapies to be Evaluated as Treatment for Relapsed Acute Promyelocytic Leukemia.			Sep 14, 2009	1207
Acute myeloid leukemia in Turkish children with Fanconi anemia. One center experience in the period between 1964-1995/ Fanconi anemili Turk cocuklarinda akut miyeloid losemi. 1964-1995 doneminde bir merkezin deneyimleri.	Gozdasoglu, Sevgi; Ertem, Mehmet; Uysal, Zumrut; Babacan, Emel; Yuksel, Memnune; Bokesoy, Isik; Sung	Clinical report	Sep 1, 2009	2354
CytRx Reports Favorable Progress Update for Its Pivotal Phase 2 Clinical Trial with Tamibarotene as a Third-line Treatment for Acute Promyelocytic Leukemia.			Jun 29, 2009	1066
Misread marks and cancer.	Saey, Tina Hesman	Brief article	Jun 6, 2009	128
Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments/Akut promiyelositik losemi ve diferansiyasyon tedavisi: diferansiyasyonun, retinoik asit direncinin ve yeni tedavilerin molekuler mekanizmalari.	Ozpolat, Bulent	Report	Jun 1, 2009	12983
Acute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid/Tiroid papiller karsinomu icin verilen radyoaktif iyot tedavisi sonrasi akut miyeloid losemi.	Ankit, Jain; Premalata, C.S.; Saini, K.V.; Bapsy, P.P.; Sajeevan, K.V.; Singh, Tejinder; Batra, Ulla	Case study	Jun 1, 2009	1595
Haematological & molecular profile of acute myelogenous leukaemia in India.	Sazawal, Sudha; Kumar, Bijender; Hasan, Syed khizer; Dutta, Pankhi; Kumar, Rajat; Chaubey, Rekha; Mi	Report	Mar 1, 2009	3944
Seattle Genetics Completes Enrollment in Lintuzumab Phase IIb Clinical Trial for Patients with Acute Myeloid Leukemia.			Feb 25, 2009	696
Ambit Biosciences Presents Data on its Targeted Cancer Therapeutic AC220 for Acute Myeloid Leukemia.			Dec 9, 2008	1477
Data Presented at this Year's ASH Meeting Demonstrate Prolonged Overall Survival for Patients with Acute Myeloid Leukemia.			Dec 9, 2008	457
Significance of molecular-cytogenetic aberrations for the achievement of first remission in de novo acute myeloid leukemia/Dogustan olmayan akut miyeloid losemiye yonelik ilk gerilemenin kazanilmasinda molekuler sitogenetik aberasyonlarin onemi.	Velizarova, Milena G.; Hadjiev, Evgueniy A.; Alexandrova, Kamelia V.; Popova, Dora N.; Dimova, Ivank	Clinical report	Dec 1, 2008	3424
Acute myeloblastic leukemia-associated Marfan syndrome and Davidoff-Dyke-Masson syndrome: a case report/Akut myeloblastik losemi ile Marfan sendromu ve Davidoff-Dyke-Masson sendromu birlikteligi: Bir Olgu Sunumu.	Demir, Cengiz; Bay, Ali; Dilek, Imdat; Oner, Ahmet Faik	Case study	Dec 1, 2008	1612
In patients with acute myelogenous leukemia (AML) undergoing a standard 7-day course of chemotherapy, positron emission tomography (PET) using the radiotracer fluoro-L-thymidine (FLT).			Aug 4, 2008	382
External beam radiation increases risk of leukemia.	Lowry, Fran	Clinical report	Aug 1, 2008	454
Alabama Supreme Court ends toxic-tort catch-22.	Porter, Rebecca		Apr 1, 2008	660
Xenomics Announces License with Warnex of Acute Myeloid Leukemia Assay.			Feb 21, 2008	469
Seattle Genetics Reports Multiple Complete Remissions With SGN-33 in Acute Myeloid Leukemia at ASH.			Dec 10, 2007	1029
Xanthus' Xanafide Bypasses Multi-Drug Resistance Proteins in Acute Myeloid Leukemia.			Dec 10, 2007	976
Ambit Biosciences Presents Data on AC220 in Acute Myeloid Leukemia at American Society for Hematology Conference.		Conference news	Dec 8, 2007	710
Seattle Genetics Initiates Phase IIb Clinical Trial of SGN-33 in Combination with Chemotherapy for Acute Myeloid Leukemia.			Nov 9, 2007	767
European Commission Grants Orphan Drug Designation to Xanthus' Xanafide for the Treatment of Acute Myeloid Leukemia.			Oct 26, 2007	708
INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug Designation for Tamibarotene for the Treatment of Acute Promyelocytic Leukemia.			Oct 15, 2007	874
Xanthus Initiates Pivotal Phase 3 Trial of Xanafide in Secondary Acute Myeloid Leukemia.			Oct 8, 2007	680
An HIV-associated mediastinal germ cell tumour complicated by acute myeloid leukaemia.	Young, A.M.; Powles, T.; Holmes, P.; Wang, J.; Nelson, M.; Anderson, J.; Bower, M.D.; Brock, C.S.	Case study	Sep 1, 2007	2945
INNOVIVE Pharmaceuticals.		Brief article	Sep 1, 2007	159
Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice.			Aug 8, 2007	727
INNOVIVE Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Phase II Clinical Trial with Tamibarotene in Refractory Acute Promyelocytic Leukemia.			Aug 3, 2007	1167
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia.			Jul 11, 2007	1129
Xanthus Completes Special Protocol Assessment with FDA for Phase 3 Registration Trial of Xanafide in Patients with Secondary Acute Myeloid Leukemia.		Clinical report	Jun 12, 2007	678
INNOVIVE Pharmaceuticals Receives FDA Fast Track Designation for Tamibarotene for the Treatment of Acute Promyelocytic Leukemia.			Jun 7, 2007	948
Human interaction is key to effective patient education.	Wujcik, Debra	Editorial	May 1, 2007	427
Myeloid sarcoma presenting as an isolated nodule in a patient with acute myelogenous leukemia.	Bhatia, Neal; Wallace, Timothy; Divgi, Ajit; Short, Vicky	Clinical report	Apr 1, 2007	2255
Childhood and young adult AML: long-term survival favorable.	Worcester, Sharon	Clinical report	Mar 15, 2007	461
Rapid detection of nucleophosmin (NPM1) mutations in acute myeloid leukemia by denaturing HPLC.	Ammatuna, Emanuele; Noguera, Nelida Ines; Zangrilli, Daniela; Curzi, Paola; Panetta, Paola; Benciven		Nov 1, 2005	1756
Myeloid sarcoma.	Thompson, Lester D.R.		Aug 1, 2005	498
Novel drug fights leukemia leukemia.		Brief Article	Jan 10, 2004	204
Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC.	Bianchini, Michele; Ottaviani, Emanuela; Grafone, Tiziana; Giannini, Barbara; Soverini, Simona; Terr		Oct 1, 2003	4481
Molecular monitoring of acute promyelocytic leukemia by DzyNA reverse transcription-PCR.	Applegate, Tanya L.; Iland, Harry J.; Mokany, Elisa; Todd, Alison V.		Oct 1, 2002	1849
Diagnosis and molecular monitoring of acute promyelocytic leukemia using DzyNA reverse transcription-PCR to quantify PML/RAR[alpha] fusion transcripts.	Applegate, Tanya L.; Iland, Harry J.; Mokany, Elisa; Todd, Alison V.		Aug 1, 2002	4425
Leukemia treatments nearing prime time. (Smart Drugs).	Seppa, N.	Brief Article	Jun 15, 2002	624
Risk factors for acute myeloid leukemia and multiple myeloma: a combination of GIS and case-control studies. (Features).	Anton-Culver, Hoda	Statistical Data Included	Mar 1, 2002	5981
Breast cancer chemo linked to leukemia. ('Alarming' New Finding).	Jancin, Bruce		Feb 15, 2002	162
c-Kit (CD117) reactivity in extramedullary myeloid tumor/granulocytic sarcoma.	Chen, Jian; Yanuck, Rudolph R., III; Abbondanzo, Susan L.; Chu, Wei-Sing; Aguilera, Nadine S.I.		Nov 1, 2001	2886
Cauda equina syndrome in a 65-year-old man, status post-bone marrow transplant for chronic myeloid leukemia. (Pathologic Quiz Case).	Dalton, Scott R.; Ririe, David W.; Neuhauser, Thomas S.		Oct 1, 2001	1097
Head and neck granulocytic sarcoma with acute myeloid leukemia: Three rare cases.	Dilek, Imdat		Apr 1, 2001	2079
Genetic defect needs aggressive treatment.		Brief Article	Oct 1, 1998	382
Arsenic: a novel cancer remedy?	Fackelmann, Kathleen	Brief Article	Apr 11, 1998	168
Better leukemia survival.	Raloff, Janet	Brief Article	Oct 8, 1994	341
New treatment shuts off oncogene.		Brief Article	Jun 6, 1992	264